ArticleScientific reports2026
Biosynthesis of cerium and gadolinium nanoparticles by Pseudomonas putida KT2440 enables sustainable rare earth elements utilization.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Challenges in Evaluating Nirsevimab Effectiveness Across Pre- and Post-Pandemic Settings.Indian pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lanthanides (Ln), a group of 15 rare earth elements (REEs), are critical for advanced technologies, although their conventional extraction and processing are environmentally unsustainable. Here, we present a microbial platform based on Pseudomonas putida KT2440 for the eco-friendly recovery and transformation of Ln, introducing a key methodological innovation: the use of a resting cell system to circumvent the pervasive issue of abiotic lanthanide-phosphate precipitation. This approach enables controlled investigation of Ln biomineralization under mild conditions. Mechanistically, the results showed that Ln recovery proceeds via rapid cell-surface adsorption, followed by surface-templated nucleation and extracellular mineralization. This process leads to the formation of well-defined biogenic nanoparticles primary identified as CePO₄ and GdPO₄. Structural analyses reveal nanorod morphologies, while functional characterization shows that CePO₄ nanoparticles retain photoluminescent properties and GdPO₄ nanoparticles preserve paramagnetic behavior. Compared to conventional chemical synthesis, this biosynthetic strategy eliminates toxic reagents and energy-intensive steps, yielding biocompatible materials with controlled size and morphology. Our findings establish P. putida KT2440 as an efficient and sustainable platform for Ln recovery and functional nanoparticle production, providing a foundation for scalable green alternatives to traditional Ln processing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.